DETECTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK AND MYOCARDIAL INFARCTION RISK

摘要

Methods are disclosed herein for determining the likelihood that a subject will develop atherosclerotic cardiovascular disease (ASCVD) or a myocardial infarction (MI). Methods are also disclosed for determining if a pharmaceutical agent is effective for the treatment or prevention of ASCVD. In additional embodiments, methods are disclosed for determining if a pharmaceutical agent is of use in preventing an MI.